<VariationArchive VariationID="15875" VariationName="NM_000558.5(HBA1):c.188_190del (p.Val63del)" VariationType="Deletion" Accession="VCV000015875" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2020-05-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30914" VariationID="15875">
      <GeneList>
        <Gene Symbol="HBA1" FullName="hemoglobin subunit alpha 1" GeneID="3039" HGNC_ID="HGNC:4823" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="176680" stop="177522" display_start="176680" display_stop="177522" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="226678" stop="227519" display_start="226678" display_stop="227519" Strand="+" />
          </Location>
          <OMIM>141800</OMIM>
        </Gene>
        <Gene Symbol="LOC106804613" FullName="hemoglobin subunit alpha 1 recombination region" GeneID="106804613" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="174618" stop="177541" display_start="174618" display_stop="177541" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000558.5(HBA1):c.188_190del (p.Val63del)</Name>
      <CanonicalSPDI>NC_000016.10:177018:GGTGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="177019" stop="177021" display_start="177019" display_stop="177021" variantLength="3" positionVCF="177018" referenceAlleleVCF="AGGT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="227018" stop="227020" display_start="227018" display_stop="227020" variantLength="3" positionVCF="227017" referenceAlleleVCF="AGGT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>V62del</Name>
        <Name>CD 62 -GTG [-Val]</Name>
      </OtherNameList>
      <ProteinChange>V63del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.177021_177023del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.177021_177023del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.227020_227022del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.227020_227022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000006.1" sequenceAccession="NG_000006" sequenceVersion="1" change="g.37884_37886del">
            <Expression>NG_000006.1:g.37884_37886del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046166.1" sequenceAccession="NG_046166" sequenceVersion="1" change="g.2504_2506del">
            <Expression>NG_046166.1:g.2504_2506del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_059186.1" sequenceAccession="NG_059186" sequenceVersion="1" change="g.5371_5373del">
            <Expression>NG_059186.1:g.5371_5373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000558.5" sequenceAccession="NM_000558" sequenceVersion="5" change="c.188_190del" MANESelect="true">
            <Expression>NM_000558.5:c.188_190del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000549.1" sequenceAccession="NP_000549" sequenceVersion="1" change="p.Val63del">
            <Expression>NP_000549.1:p.Val63del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000006.1" sequenceAccession="NG_000006" sequenceVersion="1" change="g.37883_37885del">
            <Expression>NG_000006.1:g.37883_37885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1225" sequenceAccession="LRG_1225">
            <Expression>LRG_1225:g.5371_5373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1225t1" sequenceAccession="LRG_1225t1">
            <Expression>LRG_1225t1:c.188_190del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1225p1" sequenceAccession="LRG_1225p1" change="p.Val63del">
            <Expression>LRG_1225p1:p.Val63del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="906" DB="HBVAR" />
        <XRef ID="CA125997" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="141800.0202" DB="OMIM" />
        <XRef Type="rs" ID="35672478" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10569720 to determine the location of this allele on current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000558.5(HBA1):c.188_190del (p.Val63del) AND HEMOGLOBIN AGHIA SOPHIA" Accession="RCV000017221" Version="11">
        <ClassifiedConditionList TraitSetID="5144">
          <ClassifiedCondition>HEMOGLOBIN AGHIA SOPHIA</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-07-20" SubmissionCount="1">other</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000558.5(HBA1):c.188_190del (p.Val63del) AND Hemoglobin H disease, nondeletional" Accession="RCV000022601" Version="13">
        <ClassifiedConditionList TraitSetID="8015">
          <ClassifiedCondition DB="MedGen" ID="C3279561">Hemoglobin H disease, nondeletional</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000558.5(HBA1):c.188_190del (p.Val63del) AND alpha Thalassemia" Accession="RCV001078389" Version="10">
        <ClassifiedConditionList TraitSetID="4863">
          <ClassifiedCondition DB="MedGen" ID="C0002312">alpha Thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-11-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-25" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2020-05-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; other</Description>
        <Citation Type="general">
          <ID Source="PubMed">10569720</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://ithanet.eu/db/ithagenes?ithaID=381</URL>
        </Citation>
        <DescriptionHistory Dated="2022-03-16">
          <Description>Pathogenic, other</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5144" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12416" Type="NamedProteinVariant">
              <Name>
                <ElementValue Type="Preferred">HEMOGLOBIN AGHIA SOPHIA</ElementValue>
                <XRef Type="Allelic variant" ID="141800.0202" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="4863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6489" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">A-Thalassemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">alpha Thalassemia</ElementValue>
                <XRef ID="Alpha-Thalassemia/333" DB="Genetic Alliance" />
                <XRef ID="68913001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha thalassemia spectrum</ElementValue>
                <XRef ID="MONDO:0011399" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia (α-thalassemia) has two clinically significant forms: hemoglobin Bart hydrops fetalis (Hb Bart) syndrome (caused by deletion/inactivation of all four α-globin genes; --/--), and hemoglobin H (HbH) disease (most frequently caused by deletion/inactivation of three α-globin genes; --/-α). Hb Bart syndrome, the more severe form, is characterized by prenatal onset of generalized edema and pleural and pericardial effusions as a result of congestive heart failure induced by severe anemia. Extramedullary erythropoiesis, marked hepatosplenomegaly, and a massive placenta are common. Death usually occurs in the neonatal period. HbH disease has a broad phenotypic spectrum: although clinical features usually develop in the first years of life, HbH disease may not present until adulthood or may be diagnosed only during routine hematologic analysis in an asymptomatic individual. The majority of individuals have enlargement of the spleen (and less commonly of the liver), mild jaundice, and sometimes thalassemia-like bone changes. Individuals with HbH disease may develop gallstones and experience acute episodes of hemolysis in response to infections or exposure to oxidant drugs.</Attribute>
                <XRef ID="NBK1435" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="621" />
                <XRef ID="621" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301608</ID>
                <ID Source="BookShelf">NBK1435</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2014">
                <ID Source="PubMed">25052315</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2021">
                <ID Source="PubMed">17197616</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/HB-Screening-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Hb Screening (non-S), 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, FA + Barts Hb, Alpha (a) Thalassemia, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Barts-Present-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics Newborn Screening ACT sheet, FA + Barts present (unquantified), FAB, Alpha Thalassemia, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Barts-Present-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin FA + Barts: Unquantified Barts Alpha Thalassemia Screening Result (FAB), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Low-Moderate-Barts-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, Hemoglobin FA + Barts: Low/Moderate Barts Alpha Thalassemia Screening Result (FAB2; FAB1), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/Alpha-Thalassemia-Low-Moderate-Barts-ACT-Sheet.pdf</URL>
                <CitationText>ACMG ACT, FA + Low/Moderate Barts Hb, FAB2, FAB1 Alpha Thalassemia: Silent carrier and alpha thalassemia trait, 2023</CitationText>
              </Citation>
              <XRef ID="846" DB="Orphanet" />
              <XRef ID="C0002312" DB="MedGen" />
              <XRef ID="MONDO:0011399" DB="MONDO" />
              <XRef Type="MIM" ID="604131" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8015" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16218" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hemoglobin H disease, nondeletional</ElementValue>
              </Name>
              <XRef ID="C3279561" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37493" SubmissionDate="2016-07-20" DateLastUpdated="2016-07-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141800.0202_HEMOGLOBIN AGHIA SOPHIA" title="HBA1, VAL62DEL_HEMOGLOBIN AGHIA SOPHIA" />
        <ClinVarAccession Accession="SCV000037493" DateUpdated="2016-07-24" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>other</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Greek child with Hb H disease (613978), Traeger-Synodinos et al. (1999) found deletion of codon 62 of the alpha-1 gene, leading to alpha-plus-thalassemia. Codon 62 encodes a valine residue at the E11 alpha helix, which is located in the interior of the heme pocket. Substitutions of this valine with other amino acid residues in the alpha as well as beta polypeptide chains lead, in the heterozygous carrier, either to Hb M disease or to congenital nonspherocytic hemolytic anemia. Traeger-Synodinos et al. (1999) assumed that deletion of val at position 62 disrupted the conformation of the alpha chain to such an extent that the mutated subunit was rapidly removed by proteolysis. The final result was an alpha-thalassemia phenotype rather than an unstable hemoglobin syndrome. This conclusion was supported by the apparent absence of an abnormal alpha chain in the peripheral blood of the patient. Hb Evans (141850.0006) is a val62-to-met mutation of the HBA2 gene and was found in a patient with mild hemolytic anemia. Four amino acid substitutions at position 67(E11)val of the beta chain lead to instability of the Hb tetramer and an anemia of variable degrees in the heterozygotes. One of these substitutions, val67 to glu (141900.0163), results in the stable Hb M-Milwaukee-I.</Attribute>
              <Citation>
                <ID Source="PubMed">10569720</ID>
              </Citation>
              <XRef DB="OMIM" ID="613978" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA1" />
          </GeneList>
          <Name>HBA1, VAL62DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">VAL62DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141800.0202" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOGLOBIN AGHIA SOPHIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49146" SubmissionDate="2016-07-20" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141800.0202_HEMOGLOBIN H DISEASE, NONDELETIONAL" title="HBA1, VAL62DEL_HEMOGLOBIN H DISEASE, NONDELETIONAL" />
        <ClinVarAccession Accession="SCV000043890" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Greek child with Hb H disease (613978), Traeger-Synodinos et al. (1999) found deletion of codon 62 of the alpha-1 gene, leading to alpha-plus-thalassemia. Codon 62 encodes a valine residue at the E11 alpha helix, which is located in the interior of the heme pocket. Substitutions of this valine with other amino acid residues in the alpha as well as beta polypeptide chains lead, in the heterozygous carrier, either to Hb M disease or to congenital nonspherocytic hemolytic anemia. Traeger-Synodinos et al. (1999) assumed that deletion of val at position 62 disrupted the conformation of the alpha chain to such an extent that the mutated subunit was rapidly removed by proteolysis. The final result was an alpha-thalassemia phenotype rather than an unstable hemoglobin syndrome. This conclusion was supported by the apparent absence of an abnormal alpha chain in the peripheral blood of the patient. Hb Evans (141850.0006) is a val62-to-met mutation of the HBA2 gene and was found in a patient with mild hemolytic anemia. Four amino acid substitutions at position 67(E11)val of the beta chain lead to instability of the Hb tetramer and an anemia of variable degrees in the heterozygotes. One of these substitutions, val67 to glu (141900.0163), results in the stable Hb M-Milwaukee-I.</Attribute>
              <Citation>
                <ID Source="PubMed">10569720</ID>
              </Citation>
              <XRef DB="OMIM" ID="613978" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA1" />
          </GeneList>
          <Name>HBA1, VAL62DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">VAL62DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141800.0202" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">HEMOGLOBIN H DISEASE, NONDELETIONAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2454077" SubmissionDate="2019-11-25" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="ithaID:381|Orphanet:ORPHA:846" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001244591" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="The ITHANET community portal, The Cyprus Institute of Neurology and Genetics" OrgID="507248" OrganizationCategory="locus-specific database (LSDB)" OrgAbbreviation="ITHANET" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10569720</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBA1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>CD 62 -GTG [-Val]</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141800.0202" Type="Allelic variant" />
            <XRef DB="dbSNP" ID="35672478" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000558.5:c.188_190del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA846" />
          </Trait>
        </TraitSet>
        <Citation>
          <URL>https://ithanet.eu/db/ithagenes?ithaID=381</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB6599191</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2454077" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA846" MappingRef="Orphanet">
        <MedGen CUI="C0002312" Name="alpha Thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37493" TraitType="Disease" MappingType="Name" MappingValue="HEMOGLOBIN AGHIA SOPHIA" MappingRef="Preferred">
        <MedGen CUI="C4284265" Name="HEMOGLOBIN AGHIA SOPHIA" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49146" TraitType="Disease" MappingType="Name" MappingValue="HEMOGLOBIN H DISEASE, NONDELETIONAL" MappingRef="Alternate">
        <MedGen CUI="C3279561" Name="Hemoglobin H disease, nondeletional" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

